K ATP channel openers of the benzopyran type reach their binding site via the cytosol

British Journal of Pharmacology

Volumn 149, Issue 2, 2006, Pages 199-205

  Stephan, D ^a   Salamon, E ^b   Weber, H ^b   Russ, U ^a   Lemoine, H ^b   Quast, U ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Access to binding site; Bimakalim sulphonic acid; K ATP channel openers; Sidedness of opener effect; Sulphonylurea receptor

Indexed keywords

ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; BENZOPYRAN DERIVATIVE; BIMAKALIM; DESCYANOBIMAKALIM 6 SULFONIC ACID; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR6.2; POTASSIUM CHANNEL STIMULATING AGENT; SULFONIC ACID DERIVATIVE; SULFONYLUREA DERIVATIVE; SULFONYLUREA RECEPTOR; UNCLASSIFIED DRUG; DIHYDROPYRIDINE DERIVATIVE; MITOCHONDRIAL K(ATP) CHANNEL; POTASSIUM CHANNEL;

ARTICLE; CELL MEMBRANE; CHANNEL GATING; CONTROLLED STUDY; CYTOSOL; DRUG ACTIVITY; DRUG BINDING SITE; DRUG PROTEIN BINDING; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RECEPTOR AFFINITY; WHOLE CELL; CELL LINE; COMPARATIVE STUDY; DRUG POTENTIATION; METABOLISM;

BENZOPYRANS; CELL LINE; CYTOSOL; DIHYDROPYRIDINES; HUMANS; POTASSIUM CHANNELS;

EID: 33748518175     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/sj.bjp.0706858     Document Type: Article

References (35)

1. Ashcroft SJH, Ashcroft FM (1990). Properties and functions of ATPsensitive K-channels. Cell Signal 2: 197-214.
2. ATP channel. Diabetes 48: 1341-1347.
3. + channel openers in rat aorta. J Biol Chem 267: 11689-11692.
4. ATP channels. Curr Pharm Design 11: 2699-2716.
5. + channels. Diabetes 53: S104-S112.
6. 50) of an enzymatic reaction. Biochem Pharmacol 22: 3099-3108.
7. Christopoulos A (1998). Assessing the distribution of parameters in models of ligand-receptor interaction: to log or not to log. Trends Pharmacol Sci 19: 351-357.
8. Coghlan MJ, Carroll WA, Gopalakrishnan M (2001). Recent developments in the biology and medicinal chemistry of potassium channel modulators: update from a decade of progress. J Med Chem 44: 1627-1653.
9. + channel modulators. Diabetes 53: S128-S134.
10. + channel modulator binding to sulfonylurea receptors SUR2A and SUR2B: opposite effects of MgADP. Mol Pharmacol 55: 832-840.
11. ATP channel modulator binding to the recombinant sulphonylurea receptor, SUR2B. Br J Pharmacol 125: 577-583.
12. Hambrock A, Löffler-Walz C, Russ U, Lange U, Quast U (2001). Characterization of a mutant sulfonylurea receptor SUR2B with high affinity for sulfonylureas and openers: differences in the coupling to Kir6.x subtypes. Mol Pharmacol 60: 190-199.
13. Hescheler J, Pelzer D, Trube G, Trautwein W(1982). Does the organic calcium channel blocker D600 act from inside or outside on the cardiac cell membrane? Pflügers Arch-Eur J Physiol 393: 287-291.
14. Hille B (1977). Local anesthetics: hydrophilic and hydrophobic pathways for the drug-receptor reaction. J Gen Physiol 69: 497-515.
15. ATP channel modulators with sulfonylurea receptor SUR2B: implication for tetramer formation and allosteric coupling of subunits. Mol Pharmacol 61: 407-414.
16. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951). Protein measurement with the folin phenol reagent. J Biol Chem 193: 265-275.
17. ATP channel openers: structure-activity relationships and therapeutic potential. Med Sci Res 24: 213-266.
18. Mannhold R, Cruciani G, Weber H, Lemoine H, Derix A, Weichel C et al. (1999). 6-Substituted benzopyrans as potassium channel activators: synthesis, vasodilator properties, and multivariate analysis. J Med Chem 42: 981-991.
19. Mikhailov MV, Mikhailova EA, Ashcroft SJH (2001). Molecular structure of the glibenclamide binding site of the β-cell K-ATP channel. FEBS Lett 499: 154-160.
20. ATP channel openers. Mol Pharmacol 67: 1026-1033.
21. ATP channel openers. EMBO J 19: 6644-6651.
22. ATP channel openers. J Mol Cell Cardiol 38: 951-963.
23. 3H]P1075 in rat isolated aorta: relationship to functional effects of openers and blockers. Mol Pharmacol 43: 474-481.
24. + channel Kir6.1 increases the affinity of the vascular sulfonylurea receptor SUR2B for glibenclamide. Mol Pharmacol 56: 955-961.
25. + channels: comparison with glibenclamide. J Pharmacol Exp Ther 299: 1049-1055.
26. ATP-channel openers. J Med Chem 45: 1086-1097.
27. Schwanstecher M, Brandt C, Behrends S, Schaupp U, Panten U (1992). Effect of MgATP on pinacidil-induced displacement of glibenclamide from the sulphonylurea receptor in a pancreatic b-cell line and rat cerebral cortex. Br J Pharmacol 106: 295-301.
28. Schwanstecher M, Schwanstecher C, Dickel C, Chudziak F, Moshiri A, Panten U (1994). Location of the sulphonylurea receptor at the cytoplasmic face of the β-cell membrane. Br J Pharmacol 113: 903-911.
29. Schwanstecher M, Sieverding C, Dörschner H, Gross I, Aguilar-Bryan L, Schwanstecher C et al. (1998). Potassium channel openers require ATP to bind to and act through sulfonylurea receptors. EMBO J 17: 5529-5535.
30. + channels. Prog Biophys Mol Biol 81: 133-176.
31. Tusnády GE, Bakos E, Varadi A, Sarkadi B (1997). Membrane topology distinguishes a subfamily of the ATP-binding cassette (ABC) transporters. FEBS Lett 402: 1-3.
32. Uhde I, Toman A, Gross I, Schwanstecher C, Schwanstecher M (1999). Identification of the potassium channel opener site on sulfonylurea receptors. J Biol Chem 274: 28079-28082.
33. Van Holde KE (1971). Physical Biochemistry. Prentice-Hall Inc.: Englewood Cliffs, NJ, pp 89.
34. Weast RE (ed). (1981-1982). CRC Handbook of Chemistry and Physics Table D-142 Dissociation constants of organic acids in aqueous solution 62nd edn. CRC Press Inc.: Cleveland, OH.
35. ATP channels. Neuron 22: 537-548.